Predictive values of hCG clearance for risk of methotrexate resistance in low-risk gestational trophoblastic neoplasias.

MLA

You, B., et al. “Predictive Values of HCG Clearance for Risk of Methotrexate Resistance in Low-Risk Gestational Trophoblastic Neoplasias.” Annals of Oncology : Official Journal of the European Society for Medical Oncology, vol. 21, no. 8, Aug. 2010, pp. 1643–50. EBSCOhost, https://doi.org/10.1093/annonc/mdq033.

APA

You, B., Pollet-Villard, M., Fronton, L., Labrousse, C., Schott, A.-M., Hajri, T., Girard, P., Freyer, G., Tod, M., Tranchand, B., Colomban, O., Ribba, B., Raudrant, D., Massardier, J., Chabaud, S., & Golfier, F. (2010). Predictive values of hCG clearance for risk of methotrexate resistance in low-risk gestational trophoblastic neoplasias. Annals of Oncology : Official Journal of the European Society for Medical Oncology, 21(8), 1643–1650. https://doi.org/10.1093/annonc/mdq033

Chicago

You, B, M Pollet-Villard, L Fronton, C Labrousse, A-M Schott, T Hajri, P Girard, et al. 2010. “Predictive Values of HCG Clearance for Risk of Methotrexate Resistance in Low-Risk Gestational Trophoblastic Neoplasias.” Annals of Oncology : Official Journal of the European Society for Medical Oncology 21 (8): 1643–50. doi:10.1093/annonc/mdq033.